Investigator-Initiated Research (IIR)
The mission of the Investigator Initiated Research (IIR) Program at Mallinckrodt is to improve the lives of our patients by increasing the medical and scientific understanding of our products and related therapeutic areas. One way we can advance the knowledge base on diseases, disease management, and therapeutic outcomes is through support of independent research.
This global program is open to all academic and community-based researchers who are interested in conducting their own research. As the sponsor of the study, the investigator and/or institution assume responsibility for all aspects of the study, including:
- Study design and protocol development
- Institutional and regulatory approvals and reporting requirements
- Study conduct in accordance with ICH GCP Guidelines and all applicable local and regulatory requirements
- Dissemination of study results in peer-reviewed publications
The Grants Review Committee meets regularly to review all submissions and awards funding based on medical or scientific merit, unmet medical need, study feasibility, and availability of funds. Mallinckrodt may provide support for IIRs in the form of funding and/or study drug, depending upon the type of research.
Please submit all requests through our online portal by clicking here: Apply Now. If a concept is of interest, a request for full protocol submission will be issued. All materials submitted through this portal are done so on a non-confidential basis. By submitting your materials to Mallinckrodt for review, you understand that they will not be treated as confidential or proprietary.
For questions, please email our Late Phase Research team at StudyInfo@Mallinckrodt.com.